1 Semiconductor Stock to Consider Right Now and 2 to Turn Down
Semiconductors are the core infrastructure powering the Information Age. Still, they're subject to swings in the broader economy because customers often stockpile chips ahead of demand, and investors seem to believe that inventory levels are correcting - over the past six months, the industry has shed 23.5%. This drawdown was noticeably worse than the S&P 500's 5.2% loss.
The elite companies can churn out earnings growth under any circumstance, however, and our mission at StockStory is to help you find them. Taking that into account, here is one semiconductor stock boasting a durable advantage and two we're passing on.
Market Cap: $3.52 billion
The result of a spinoff from Sanken in Japan, Allegro MicroSystems (NASDAQ:ALGM) is a designer of power management chips and distance sensors used in electric vehicles and data centers.
Why Should You Sell ALGM?
Customers postponed purchases of its products and services this cycle as its revenue declined by 7.6% annually over the last two years
Earnings per share fell by 19.8% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
Free cash flow margin dropped by 9.4 percentage points over the last five years, implying the company became more capital intensive as competition picked up
At $18.74 per share, Allegro MicroSystems trades at 38.1x forward price-to-earnings. If you're considering ALGM for your portfolio, see our FREE research report to learn more.
Market Cap: $4.34 billion
Operating through a largely Asian facility footprint, Amkor Technologies (NASDAQ:AMKR) provides outsourced packaging and testing for semiconductors.
Why Should You Dump AMKR?
Products and services are facing significant end-market challenges during this cycle as sales have declined by 5.6% annually over the last two years
Demand will likely be weak over the next 12 months as Wall Street expects flat revenue
Gross margin of 14.6% is below its competitors, leaving less money to invest in areas like marketing and R&D
Amkor is trading at $17.70 per share, or 8.6x forward price-to-earnings. Check out our free in-depth research report to learn more about why AMKR doesn't pass our bar.
Market Cap: $91.35 billion
Founded in 1980 by David Lam, the man who pioneered semiconductor etching technology, Lam Research (NASDAQ:LRCX) is one of the leading providers of wafer fabrication equipment used to make semiconductors.
Why Are We Positive On LRCX?
Highly efficient business model is illustrated by its impressive 29.6% operating margin, and it turbocharged its profits by achieving some fixed cost leverage
LRCX is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders, and its recently improved profitability means it has even more resources to invest or distribute
ROIC punches in at 63.1%, illustrating management's expertise in identifying profitable investments
Lam Research's stock price of $71.64 implies a valuation ratio of 18.9x forward price-to-earnings. Is now a good time to buy? Find out in our full research report, it's free.
The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.
Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Why ImmunityBio, Inc. (IBRX) Skyrocketed Today
We recently published a list of . In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against other Wednesday's best-performing stocks. ImmunityBio extended its winning streak to a fifth consecutive day on Wednesday, jumping 8.1 percent to finish at $2.93 apiece as investors cheered the Food and Drug Administration's (FDA) green light for the company to expand the access of its Anktiva treatment to patients with solid tumors. According to ImmunityBio, Inc. (NASDAQ:IBRX), it was granted by the FDA to treat lymphopenia in adult patients with refractory or relapsed solid tumors. 'Lymphopenia has long been recognized as a major driver and predictor of early mortality in cancer—yet until now, it has remained unaddressed,' said ImmunityBio, Inc. (NASDAQ:IBRX) founder and Executive Chairman Patrick Soon-Shiong. A technician analyzing natural killer cells, as part of an immune system study and research into therapeutical agents. 'This FDA authorization allows all patients with solid tumors suffering from immune collapse following first-line therapy of chemo, radiation, or immunotherapy to access ANKTIVA. The survival benefit we observed at ASCO 2025 in 3rd to 6th line advanced metastatic pancreatic cancer confirms that restoring lymphocyte levels, rather than depleting them, can change the course of disease.' Following the announcement, the company earned a 'buy' recommendation and a price target of $8 from investment firm HC Wainwright. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
3 of the Cheapest Artificial Intelligence Stocks to Buy Right Now
The tech companies listed here are all investing heavily in artificial intelligence. Their valuations are modest when factoring in their long-term growth opportunities. 10 stocks we like better than Alphabet › Want to add some promising artificial intelligence (AI) stocks to your portfolio, without paying an obscene price? While many stocks are trading at inflated valuations, there are still many good options out there to consider, which can deliver strong returns for your portfolio. Three AI stocks that possess a lot of upside and are among the cheapest options for growth investors to buy right now are Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL), Alibaba Group Holdings (NYSE: BABA), and Advanced Micro Devices (NASDAQ: AMD). Here's why it may not be too late to invest in these stocks. Shares of Alphabet are down around 11% this year as investors are concerned about antitrust issues and a possible breakup of the business, or at the very least, changes to its core operations. But there's a lot to like about the business. The company is planning to spend $75 billion on capital expenditures this year as it works on creating next-generation technologies. Alphabet's core business also still looks solid. Investors shouldn't forget that while ChatGPT has been around for multiple years now, Alphabet's ad business still remains strong -- the popular chatbot hasn't made a big dent in the company's earnings. During the first three months of this year, Alphabet's revenue totaled $90.2 billion, which came in better than expectations and rose by 12% year over year. Earlier this year, it announced plans to acquire cybersecurity company Wiz for $32 billion. It's a great asset to add into the mix to enhance its growth prospects even further. Alphabet already has its own chatbot, Gemini, a robotaxi in Waymo, plus its amazingly popular core assets -- YouTube and Google Search. With an abundance of growth potential, Alphabet looks like a steal of a deal, trading at just 19 times its trailing earnings. If you're looking for more of a discounted AI stock to buy, then Alibaba may be to your liking. At 15 times its trailing earnings, its valuation is low and it compensates investors for the risk that comes with buying shares of this Chinese company. Alibaba recently released its latest AI model, Qwen3, which uses "hybrid reasoning" that can balance deep-thinking tasks alongside more standardized questions where speed is important. Tech giant Apple has partnered with Alibaba and is integrating the Chinese company's AI in its new iPhones, which is a great testament to the effectiveness and potential for Alibaba's AI in the future. During the first three months of the year, Alibaba says its AI-related product revenue grew by triple digits for a seventh straight quarter. Although its total revenue grew by just 7% to $32.6 billion, Alibaba's vast business (which includes online retail, cloud, and logistics) is why its AI revenue isn't standing out more. But there's potential for it to be a huge growth catalyst for years to come. Investing in a top chipmaker is another good way to gain a position in AI. Advanced Micro Devices, also known as AMD, is one of Nvidia's main rivals. The stock doesn't look terribly cheap as it's trading at a price-to-earnings multiple of 80. But when you look at its price/earnings-to-growth (PEG) multiple, which factors in how much growth analysts are expecting over the coming years, that ratio is at less than 0.6. For growth investors, anything less than one is a good multiple for PEG, and AMD is well below that level. The company's business has been doing well recently with AMD's revenue rising by 36% for the period ending March 29, totaling $7.4 billion. Its new AI chips are proving to be in high demand, and if the company can keep on this pace, then there could be a lot of upside for AMD down the road. CEO Lisa Su has previously forecast that its AI chip business could bring in tens of billions in potential revenue in the future. And if those projections turn out true, then this could indeed become one of the best AI stocks to buy right now. Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Apple, and Nvidia. The Motley Fool recommends Alibaba Group. The Motley Fool has a disclosure policy. 3 of the Cheapest Artificial Intelligence Stocks to Buy Right Now was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
BofA's Hartnett Says Stocks Are Close to Setting Off Sell Signal
(Bloomberg) -- Global stocks are close to triggering a sell signal as both fund inflows and the market breadth are running too hot, says Bank of America Corp. strategist Michael Hartnett. Next Stop: Rancho Cucamonga! ICE Moves to DNA-Test Families Targeted for Deportation with New Contract Where Public Transit Systems Are Bouncing Back Around the World US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents Warn The Global Struggle to Build Safer Cars He cited a data point that stock and high-yield bond inflows have totaled 0.9% of fund managers' overall assets in the past four weeks. In his view, investors should sell if the ratio increases to more than 1%. At the same time, about 84% of country indexes are trading above their 50- and 200-day moving averages, suggesting the market is in overbought territory, Hartnett said. Global equities hit a record high this week on optimism around US-China trade negotiations and as robust economic data eased recession fears in the US. The focus later on Friday is on the US jobs report as investors look for confirmation of a healthy labor market. In terms of flows, global equity funds have attracted about $515 billion so far this year, tracking their second-biggest inflows on record, according to the weekly Bank of America note citing EPFR Global data. Hartnett has recommended international equities over US stocks, adding that the S&P 500's rebound is not supported by earnings growth. The index closed Thursday at 5,939.30 points, about 3% below its February record. --With assistance from Michael Msika. Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again YouTube Is Swallowing TV Whole, and It's Coming for the Sitcom Millions of Americans Are Obsessed With This Japanese Barbecue Sauce Is Elon Musk's Political Capital Spent? Trump Considers Deporting Migrants to Rwanda After the UK Decides Not To ©2025 Bloomberg L.P.
